Ask AI
ProCE Banner Activity

Bispecific Antibody Therapy: A Guide to Navigating Your Myeloma Treatment Journey 

PDF

A resource for providers to share with their patients to help them understand bispecific antibody treatment for multiple myeloma.

Released: June 22, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson

Target Audience

This activity is intended for hematologists, oncologists, emergency medicine physicians, neurologists, infectious disease specialists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals caring for patients with multiple myeloma who are eligible for or receiving bispecific antibody therapy.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Educate patients and caregivers on the biologic rationale, mechanisms of action, administration, and treatment process for bispecific antibody therapy in R/R MM

Financial Disclosures

Primary Author

Meera Mohan, MD, MS, FACP, has no relevant financial relationships to disclose.